[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Meirow et al., 2015 - Google Patents

Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate

Meirow et al., 2015

View HTML
Document ID
6037479623842472491
Author
Meirow Y
Kanterman J
Baniyash M
Publication year
Publication venue
Frontiers in immunology

External Links

Snippet

Cancer development is dependent on intrinsic cellular changes as well as inflammatory factors in the tumor macro and microenvironment. The inflammatory milieu nourishes the tumor and contributes to cancer progression. Numerous studies, including ours, have …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Meirow et al. Paving the road to tumor development and spreading: myeloid-derived suppressor cells are ruling the fate
Plitas et al. Regulatory T cells in cancer
Zhou et al. The role of plasmacytoid dendritic cells in cancers
Lee et al. The liver–immunity nexus and cancer immunotherapy
Weber et al. Myeloid-derived suppressor cells hinder the anti-cancer activity of immune checkpoint inhibitors
Kim et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
Ham et al. The diverse roles of the TNF axis in cancer progression and metastasis
Solito et al. Myeloid‐derived suppressor cell heterogeneity in human cancers
Shiao et al. Immune microenvironments in solid tumors: new targets for therapy
Bruno et al. Orchestration of angiogenesis by immune cells
Khaled et al. Myeloid‐derived suppressor cells in cancer: recent progress and prospects
Romero et al. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer
Zhang et al. A rosetta stone for breast cancer: prognostic value and dynamic regulation of neutrophil in tumor microenvironment
Haruna et al. The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer
Mantovani et al. Pharmacological modulation of monocytes and macrophages
Plesca et al. Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance
Jäkel et al. An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells
Sun et al. Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells
Clappaert et al. Diamonds in the rough: harnessing tumor-associated myeloid cells for cancer therapy
Sayegh et al. Complement anaphylatoxins as immune regulators in cancer
Jung et al. Dendritic cell-based immunotherapy for solid tumors
Schoenhals et al. Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Subtil et al. The therapeutic potential of tackling tumor-induced dendritic cell dysfunction in colorectal cancer
Younos et al. Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets
Liu et al. A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity